For research use only. Not for therapeutic Use.
BMS-986104(Cat No.:I003817)is a selective sphingosine-1-phosphate receptor modulator crucial for advanced immunological and neurological research. Known for its potential in treating autoimmune diseases such as multiple sclerosis, it plays a significant role in studying immune cell trafficking and neuroprotection. This high-purity compound ensures precise and reliable analytical results, making it ideal for experimental setups focused on drug development and disease mechanism exploration. BMS-986104 supports robust investigations into novel therapeutic strategies, offering significant potential in immunology and neurology, and enhancing the understanding of its modulatory effects on the immune system and nervous system.
Catalog Number | I003817 |
CAS Number | 1622180-31-7 |
Synonyms | BMS-986104; BMS 986104; BMS986104.;((1R,3S)‑1-Amino-3-((R)‑6-hexyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol |
Molecular Formula | C22H35NO |
Purity | ≥95% |
Target | S1P1 receptor modulator |
Solubility | Soluble in DMSO |
Storage | 0 - 4 °C for short term or -20 °C for long term |
IUPAC Name | [(1R,3S)-1-amino-3-[(6R)-6-hexyl-5,6,7,8-tetrahydronaphthalen-2-yl]cyclopentyl]methanol |
InChI | InChI=1S/C22H35NO/c1-2-3-4-5-6-17-7-8-19-14-20(10-9-18(19)13-17)21-11-12-22(23,15-21)16-24/h9-10,14,17,21,24H,2-8,11-13,15-16,23H2,1H3/t17-,21+,22-/m1/s1 |
InChIKey | BPMMYKAHRIEVDH-VOQZNFBZSA-N |
SMILES | CCCCCCC1CCC2=C(C1)C=CC(=C2)C3CCC(C3)(CO)N |